BTC Network Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • BTC Network's estimated annual revenue is currently $46M per year.(i)
  • BTC Network's estimated revenue per employee is $201,000

Employee Data

  • BTC Network has 229 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

What Is BTC Network?

BTC Network works on behalf of leading pharmaceutical companies and CROs to excel in the identification, recruitment, and retention of patients. BTC Network’s number one focus is patient centricity. By working with BTC Network, sponsors and CROs have access to a fully integrated network of high performing and experienced sites with strong research infrastructures and access to large clinic populations, expediting enrollment.

keywords:N/A

N/A

Total Funding

229

Number of Employees

$46M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

BTC Network News

2022-04-19 - Bitcoin Lightning Better For Payments, Morgan Stanley Says

U.S. bank Morgan Stanley published a report on Bitcoin and its second-layer payment solution Lightning Network. This BTC-based use case...

2022-04-17 - BTC Lightning Network April 2022 stat invokes the aid of bulls

Bitcoin might be the coin that defined the crypto industry as we know it today, but the Bitcoin Lightning Network could be the solution...

2022-04-13 - Binance and Coinbase silent on Bitcoin Lightning: Community tries to understand why

The Lightning Network implementation may be against business plans of some crypto exchanges, or simply not a priority for others,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$71.3M2403%N/A
#2
$71.3M240-18%N/A
#3
$35M25332%N/A
#4
N/A2576%N/A
#5
$81.1M2736%N/A